Aspira Womens Net Worth
Aspira Womens Net Worth Breakdown | AWH |
Aspira Womens Net Worth Analysis
Aspira Womens' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Aspira Womens' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Aspira Womens' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Aspira Womens' net worth analysis. One common approach is to calculate Aspira Womens' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Aspira Womens' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Aspira Womens' net worth. This approach calculates the present value of Aspira Womens' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Aspira Womens' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Aspira Womens' net worth. This involves comparing Aspira Womens' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Aspira Womens' net worth relative to its peers.
Enterprise Value |
|
To determine if Aspira Womens is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Aspira Womens' net worth research are outlined below:
| Aspira Womens Health generated a negative expected return over the last 90 days | |
| Aspira Womens Health has some characteristics of a very speculative penny stock | |
| Aspira Womens Health has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 9.15 M. Reported Net Loss for the year was (16.69 M) with profit before taxes, overhead, and interest of 4.32 M. | |
| Aspira Womens Health has about 20.48 M in cash with (15.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. | |
| Aspira Womens Health has a poor financial position based on the latest SEC disclosures | |
| Roughly 31.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Aspira Womens Health Inc Q3 2024 Earnings Call Highlights Strategic Wins Amidst Market ... |
Aspira Womens Quarterly Good Will |
|
Aspira Womens uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Aspira Womens Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aspira Womens' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Aspira Womens' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Aspira Womens is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aspira Womens Health backward and forwards among themselves. Aspira Womens' institutional investor refers to the entity that pools money to purchase Aspira Womens' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | M&t Bank Corp | 2024-06-30 | 15 K | Two Sigma Securities, Llc | 2024-06-30 | 13.5 K | Squarepoint Ops Llc | 2024-06-30 | 12.3 K | Hrt Financial Llc | 2024-06-30 | 10.9 K | Tower Research Capital Llc | 2024-06-30 | 6.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 4.8 K | Royal Bank Of Canada | 2024-06-30 | 2.3 K | Advisor Group Holdings, Inc. | 2024-06-30 | 2.3 K | Jpmorgan Chase & Co | 2024-06-30 | 2.1 K | Armistice Capital, Llc | 2024-09-30 | 1.3 M | Vanguard Group Inc | 2024-09-30 | 274.1 K |
Follow Aspira Womens' market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 13.5 M.Market Cap |
|
Project Aspira Womens' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.67) | (2.53) | |
| Return On Capital Employed | (16.49) | (15.67) | |
| Return On Assets | (2.67) | (2.53) | |
| Return On Equity | 7.06 | 7.41 |
When accessing Aspira Womens' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Aspira Womens' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Aspira Womens' profitability and make more informed investment decisions.
Evaluate Aspira Womens' management efficiency
Aspira Womens Health has Return on Asset of (1.8571) % which means that on every $100 spent on assets, it lost $1.8571. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (7.2345) %, meaning that it generated no profit with money invested by stockholders. Aspira Womens' management efficiency ratios could be used to measure how well Aspira Womens manages its routine affairs as well as how well it operates its assets and liabilities. The Aspira Womens' current Return On Equity is estimated to increase to 7.41, while Return On Tangible Assets are forecasted to increase to (2.53). As of now, Aspira Womens' Fixed Asset Turnover is increasing as compared to previous years. The Aspira Womens' current Asset Turnover is estimated to increase to 1.53, while Total Assets are projected to decrease to under 5.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.26) | (0.24) | |
| Tangible Book Value Per Share | (0.26) | (0.24) | |
| Enterprise Value Over EBITDA | (2.30) | (2.41) | |
| Price Book Value Ratio | (15.93) | (15.13) | |
| Enterprise Value Multiple | (2.30) | (2.41) | |
| Price Fair Value | (15.93) | (15.13) | |
| Enterprise Value | 34.1 M | 32.4 M |
Effective management at Aspira Womens has been a driving force behind its market achievements. We assess the correlation between management practices and financial success to determine the stock's value.
Enterprise Value Revenue 1.5072 | Revenue 8.9 M | Quarterly Revenue Growth (0.03) | Revenue Per Share 0.801 | Return On Equity (7.23) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aspira Womens insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aspira Womens' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aspira Womens insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aspira Womens time-series forecasting models is one of many Aspira Womens' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aspira Womens' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Aspira Womens Earnings per Share Projection vs Actual
Aspira Womens Corporate Management
| Michelle Snider | Senior Operations | Profile | |
| Ryan MD | Chief Officer | Profile | |
| Emily Granger | Director Marketing | Profile | |
| Robert CPA | Chief Officer | Profile | |
| Michael Newton | VP Commercial | Profile | |
| Marlene McLennan | Interim Officer | Profile |
Already Invested in Aspira Womens Health?
The danger of trading Aspira Womens Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aspira Womens is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aspira Womens. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aspira Womens Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.801 | Quarterly Revenue Growth (0.03) | Return On Assets (1.86) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.